| Variation | | Type (Consequence) | Condition | Classification, Review status |
---|
| | | Single nucleotide variant (missense variant) | not provided +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Charcot-Marie-Tooth disease type 2 +3 more | |
| | BSCL2, HNRNPUL2-BSCL2 (A369V +2 more) | Single nucleotide variant (non-coding transcript variant +2 more) | Hereditary spastic paraplegia +5 more | |
| | BSCL2, HNRNPUL2-BSCL2 (L427P +2 more) | Single nucleotide variant (non-coding transcript variant +2 more) | Hereditary spastic paraplegia +10 more | GConflicting classifications of pathogenicity |
| | BSCL2, HNRNPUL2-BSCL2 (G337E +2 more) | Single nucleotide variant (non-coding transcript variant +2 more) | Charcot-Marie-Tooth disease type 2 +6 more | |
| | BSCL2, HNRNPUL2-BSCL2 (R265Q +1 more) | Single nucleotide variant (non-coding transcript variant +2 more) | Congenital generalized lipodystrophy type 2 +5 more | |
| | BSCL2, HNRNPUL2-BSCL2 (G45S) | Single nucleotide variant (non-coding transcript variant +2 more) | Congenital generalized lipodystrophy type 2 +6 more | |
| | | Single nucleotide variant (missense variant) | Pyridoxal phosphate-responsive seizures +2 more | |
Click to view in NCBI Gene